Europe Viscosupplementation Market - Industry Trends and Forecast to 2030
Europe viscosupplementation market is expected to reach USD 821.05 Million by 2030 from USD 444.24 Million in 2022, growing at a lucrative CAGR of 8.0% in the forecast period of 2023 to 2030.
Market Segmentation:Europe Viscosupplementation Market, By Source (Non-animal Origin and Animal Origin), Molecular Weight (Intermediate Molecular Weight, Low Molecular Weight, and High Molecular Weight), Injection (Single Injection, Three Injection, and Five Injection), Age Group (Geriatric and Adult), End User (Hospitals, Orthopaedic Clinics, Ambulatory Care Center, and Others), Distribution Channel (Direct Tender and Retail Sales), Country (Germany, France, U.K., Italy, Spain, Russia, Turkey, Netherlands, Switzerland, Poland, Austria, Hungary, Portugal, Norway, Ireland, and Rest of Europe) - Industry Trends and Forecast to 2030
Overview of Europe Viscosupplementation Market Dynamics:Driver
• Technological advancement in viscosupplementation
Restraint
• Product recall procedures
Opportunity
• Safety and effectiveness of intra-articular hyaluronic acid (IAHA)
Market Players:Some of the key market players operating in the Europe viscosupplementation market are listed below: • Anika Therapeutics, Inc.
• APTISSEN
• Bioventus
• Ferring B.V
• Fidia Farmaceutici S.p.A.
• IBSA Institut Biochimique SA
• Johnson & Johnson Services, Inc.
• LG Chem.
• sanofi-aventis U.S. LLC
• SEIKAGAKU CORPORATION
• TBR CHEMEDICA SA
• Teva Pharmaceuticals Industries Ltd.
• Viatris Inc.
• Zimmer Biomet
Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.
Please note: This publisher does offer titles that are created upon receipt of order. The report will take approximately 15-20 business days to prepare and deliver.